bit.bio

bit.bio is a biotech company in Cambridge, United Kingdom, founded in 2016. It has raised $249.5M across 5 rounds, most recently a $25.0M Series D in November 2026.

Synthetic biology for human health

Headquarters
Cambridge
Employees
51–200
Founded
2016
Business Model
B2B
Website
bit.bio
Total Funding
$249.5M
Last Round
$25.0M Series DNov 2026
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds for this company. The full record is or through the API.

About

bit.bio manufactures induced-pluripotent-stem-cell-derived human cells for drug discovery, disease modeling, and cell-therapy research. Founded in 2016 as a University of Cambridge spinout, the company is headquartered in Cambridge, UK. Its core technology, opti-ox, is a precision gene-targeting method for reprogramming stem cells into specific human cell types with high purity and batch consistency; branded product lines include ioCells (research-grade neurons, immune cells, and hepatocytes), the ioScreen CRISPR screening service, and the txCells cell-therapy pipeline. bit.bio has raised approximately $225 million from investors including ARCH Venture Partners, Charles River Laboratories, Foresite Capital, National Resilience, and Tencent, and employs between 51 and 200 people.

Summary

It lists 51–200 employees. It has raised $249.5M in total across 5 rounds, most recently a $25.0M Series D round in Nov 2026.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series DSeries DNov 2026
$25.0M

Sign up to see all 5 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

bit.bio on Indexed.vc
<a href="https://indexed.vc/companies/bit-bio"><img src="https://indexed.vc/api/badge/company/bit-bio" alt="bit.bio on Indexed.vc" width="260" height="76" /></a>